Clinical Trials Logo

Chemotherapy clinical trials

View clinical trials related to Chemotherapy.

Filter by:

NCT ID: NCT00211601 Completed - Clinical trials for Chemotherapy Induced Nausea and Vomiting

Study of Chemotherapy and Patient Health Outcomes for Nausea and Emesis (0000-041)

C-PHONE
Start date: August 2004
Phase: N/A
Study type: Interventional

The purpose of this study is to assess whether timely feedback to providers on patient experiences with delayed chemotherapy induced nausea and vomiting (CINV) lead to differences in patient outcomes for subsequent cycles.

NCT ID: NCT00208260 Completed - Colorectal Cancer Clinical Trials

Intensified Chemotherapy in CRC After Resection of Liver Metastases

Start date: April 2004
Phase: Phase 2/Phase 3
Study type: Interventional

Randomized, open label, multicentre phase II trial followed by phase III comparing overall survival after having selected the best experimental arm.

NCT ID: NCT00178373 Completed - Cancer Clinical Trials

Modafinil to Reduce Persistent Fatigue in Patients Following Treatment for Cancer

Start date: May 2004
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the efficacy of modafinil with regard to reducing cancer-related fatigue in cancer patients following chemotherapy or radiation therapy. Secondarily, the effect of modafinil on cognitive dysfunction in the same population will be assessed. The researchers hypothesize that administering modafinil (PROVIGIL®) to patients experiencing fatigue following completion of cancer treatment will lead to reduction in patient fatigue and prevention of or improvement in patient cognitive dysfunction.

NCT ID: NCT00104403 Completed - Clinical trials for Chemotherapy-Induced Nausea and Vomiting

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Start date: December 2004
Phase: Phase 2
Study type: Interventional

This study was designed to assess the safety and efficacy of different dosages and administration schedules of an investigational agent administered over 3 days when added to standard therapy used in the prevention of chemotherapy-induced nausea and vomiting in cancer patients. Subjects will be asked to complete daily diaries while on study medication. In addition subjects will be required to return to the investigational site several times during the course of the study for follow up safety assessments which may include blood samples for hematology and chemistry evaluations as well as physical exams. A final assessment will be preformed on study Day 20-30 at which time the subject will complete the study.

NCT ID: NCT00086762 Completed - Breast Cancer Clinical Trials

Mindfulness Relaxation Compared With Relaxing Music and Standard Symptom Management Education in Treating Patients Who Are Undergoing Chemotherapy For Newly Diagnosed Solid Tumors

Start date: June 2004
Phase: N/A
Study type: Interventional

RATIONALE: Mindfulness relaxation, a technique to help patients quiet their thoughts and relax their bodies before and during chemotherapy, may reduce or prevent nausea and vomiting. It may also help improve mental health, quality of life, and immune function in patients receiving chemotherapy. PURPOSE: This randomized clinical trial is studying mindfulness relaxation to see how well it works compared to relaxing music or standard symptom management education in treating patients who are receiving chemotherapy for newly diagnosed solid tumors.

NCT ID: NCT00065221 Completed - Nausea Clinical Trials

Ginger Control of Chemotherapy Induced Nausea and Vomiting

Start date: June 2003
Phase: Phase 2
Study type: Interventional

This is a trial to determine the safety and efficacy of ginger in reducing the prevalence and severity of chemotherapy induced nausea and vomiting.

NCT ID: NCT00041795 Completed - Clinical trials for Chemotherapy-Induced Peripheral Neuropathy

Neotrofin for Treatment of Chemotherapy-Induced Peripheral Neuropathy

Start date: January 2002
Phase: Phase 2
Study type: Interventional

This study will assess the safety and efficacy of Neotrofin in treating the peripheral neuropathy that results from chemotherapy for cancer.

NCT ID: NCT00037804 Completed - Chemotherapy Clinical Trials

Irinotecan in Treating Patients With Refractory Solid Tumors and Liver Dysfunction

Start date: n/a
Phase: Phase 1
Study type: Interventional

Drugs used in chemotherapy us different ways to stop tumor cells from dividing so they stop growing or die. Irinotecan may be effective in treating patients with refractory solid tumors and liver dysfunction.